Psoriatic arthropathy
RecruitingTulisokibart for Psoriatic Arthritis in Adults
Tulisokibart for Psoriatic Arthritis in Adults
- Disease:Psoriatic arthropathy
- Substances:Tulisokibart
Poland- Participants:18–64 years · 65+ years
- Substances:Tulisokibart
Rare diseases
Investigational molecules
Locations
Tulisokibart for Psoriatic Arthritis in Adults
PolandA study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.
PolandA study of acalabrutinib and venetoclax for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have relapsed after initial treatment
PolandA study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.
PolandStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
Poland
PolandMaintenance Therapy Study of Inavolisib with Pertuzumab and Trastuzumab in Patients with HER2‑Positive, PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer
PolandA study to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight and type 2 diabetes
PolandA study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis
PolandStudy of ASP-1929 and pembrolizumab for patients with recurrent head and neck squamous cell carcinoma without distant metastases
PolandA study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.
PolandA study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.